Helius Therapeutics
Bethany Reade has extensive experience in quality assurance and operations management within the pharmaceutical and biotechnology sectors. Currently serving as Technical Operations Manager at Helius Therapeutics since June 2020, Bethany has previously held roles as Production Manager and Operations Project Manager within the same company. Prior experience includes a position as GMP Business Systems Manager at API Consumer Brands, where expertise in AX Dynamics system was developed. Earlier career highlights include serving as QA Manager at Living Cell Technologies Limited, ensuring compliance with GMP and other regulatory standards, and holding QA Officer roles at Living Cell Technologies NZ / Diatranz Otsuka Ltd and Mylan NZ, focusing on quality control and regulatory compliance. Educationally, Bethany holds a Bachelor of Science degree in Genetics along with Physiological & Molecular Plant Biology from Massey University, completed in 2001.
Helius Therapeutics
8 followers
Helius is a New Zealand-owned biotechnology company focused on medicinal cannabis research and development. The country’s largest licensed producer and the first medicinal cannabis cultivator to be certified as New Zealand Grown through Buy NZ Made Campaign, Helius a leader in this nascent market. The company operates a state-of-the-art GMP facility in Auckland with indoor controlled growing systems, integrated extraction site, an advanced cannabinoid research laboratory and manufacturing operations. Following changes in New Zealand’s regulatory environment, Helius is poised to set the standard for effective and accessible medicinal cannabis products.